Adapt technology to the market
Release date: 2009-06-05
——Experts and scholars advise on the development of biomedical materials industry
Authoritative expert: Industry development faces many problems
Related companies: Calling for policy and technical support research institutions:
The industrial structure is irrational, the quality of some products is unstable, and the conversion rate of technological achievements is low. China's biomedical materials industry faces many problems. Recently, Shi Changxu, Zhang Xingdong, Lu Shibi, Gao Runlin, Zhou Lian, five academicians, as well as industry experts from Beijing New Materials Development Center and China Medical Device Industry Association and representatives of relevant enterprises on the status of China's biomedical materials and implantable devices industry, The issues of accelerating the development of biomedical materials and implanted devices in China were discussed in depth.
Experts:
Industry development faces many problems
In recent years, China's biomedical materials industry has made great progress. In 2008, the total output value of biomedical materials in China reached 220 billion yuan, a year-on-year increase of 15%, and the profits reached more than 20 billion yuan. More than 120 enterprises with an output value of over 100 million yuan. However, at present, domestic research on biomedical materials is still based on imitation, lacking innovative products with independent intellectual property rights; too few large enterprises engaged in the production of biomedical materials, among the nearly 5,000 companies producing biomedical materials, only One is a listed company; the main raw materials for biomedical materials are also imported. After analyzing the status quo of China's biomedical materials industry, experts believe that the “bottleneck†that limits the development of China's biomedical materials industry lies in the fact that technology cannot adapt to the market. The disconnection between technology and management, weak engineering and insufficient capital investment have resulted in slower transformation of research results and lower industrialization.
In this regard, Professor Zhang Xingdong of the Chinese Academy of Engineering and Sichuan University also said that China's biomedical materials industry is small in scale, low in labor productivity, and technologically advanced, and has a large gap with the international community. At present, China's large-scale export of biomedical materials is low-tech technical cotton, gauze, gloves, massage equipment, etc., while the bulk imports are high-tech products.
related business:
Calling for policy and technical support
Some representatives from biomedical materials manufacturers said that in recent years, the biomaterials industry has developed rapidly and the product renewal cycle is short, so companies need strong R&D capabilities and technical support. The company hopes to combine with national engineering centers, universities and research institutes with strong research and development capabilities to establish an innovation center for enterprises.
National policies have a great impact on the development of biomedical materials and their products industry, especially in terms of policies related to imported products and domestic products. Therefore, many companies have expressed the hope that the government will introduce relevant measures to protect the national industry.
Research institute:
Nanomaterials are hot spots for research and development
Experts and scholars in scientific research institutions have revealed the research direction of biomaterial science under the new situation. Some scholars have said that biocompatibility is the core of biomedical materials science. The design and synthesis of a new generation of biomaterials is the goal pursued by biomedical materials research. Nanobiomaterials and soft nanotechnology are the frontiers and hotspots of biomaterials. Advanced manufacturing methodology is a focus of biomaterials science. Surface and surface engineering is The main way to develop a new generation of biomedical materials at this stage.
Clinical experts:
Strong support for local companies
Fortunately, medical experts from clinical institutions have expressed their strong support for local biomedical materials companies.
Academician Gao Runlin of Beijing Fuwai Hospital said that some biomedical materials produced in China have improved in quality and performance, and the prices are relatively reasonable. Therefore, at present, foreign hospitals use a large number of domestic products.
However, the biomedical materials industry has a low proportion in the medical device industry in China, mostly low-tech products such as disposable articles, bone nails and bone plates, and the quality of some products is not stable enough. In this regard, clinical experts emphasize that the company's research and development products must be closely linked to clinical needs, market-oriented, and continuous technological innovation.
Suggest:
Focus on developing a large and wide range of products
It is worth noting that at this meeting, the participating experts, scholars and industry insiders put forward three suggestions for the development of China's biomedical materials industry: one is oriented to the development direction of contemporary biomedical materials, with a focus on large-scale development. Wide-ranging products, improving product technology and quality level, basically achieving self-sufficiency and partial export of mid-end products, meeting the needs of basic medical care for biomedical materials technology and products; second, realizing the institutional and technological innovation of China's biomedical materials industry and Integration, the formation of a number of major patent products with independent intellectual property rights, enhance the competitiveness of products in the domestic and foreign markets; Third, vigorously develop large enterprises or enterprise clusters, form large-scale production, and realize industries dominated by small and medium-sized enterprises. Structure, to the large-scale enterprises or enterprise clusters to promote the industrial restructuring of the development of small and medium-sized enterprises, to lay the foundation for the development of China's high-tech biomedical materials industry by leaps and bounds, and to catch up with the international advanced level.
(China Medical News)
Our Pp Resin has a very stable physical and chemical properties according to our professional tests. In addition to the great resistance of shocking strength and other mechanics performance, it also has a good processing performance. Our products have a high heat resistance property which allows us to apply the products in a high temperature environment. Also, the resin pellet has a lazy chemical property, it will not have a react with our daily medical medicine easily. And this also gives us a safety guarantee.
Pp Resin For Soft Bottle,Pp Copolymer Resin,Polypropylene Resin,Pp Homopolymer Resin For Bottle
SUZHOU CRH PHARMACEUTICAL TECHNOLOGY CO.,LTD , https://www.crh-health.com